# A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis

> **NCT00214721** · PHASE3 · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 120 (—)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DRUG:** Experimental Peritoneal Dialysis Solution

## Key facts

- **NCT ID:** NCT00214721
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 120 (—)
- **Last updated:** 2025-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214721, "A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00214721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*